Printer Friendly

CELOX GRANTS DISTRIBUTION RIGHTS IN JAPAN

 MINNEAPOLIS, Jan. 12 /PRNewswire/ -- Celox Corporation (NASDAQ: CELX) today announced that it has entered into an exclusive, three-year sales and distribution agreement with Funakoshi Co., Ltd. of Tokyo.
 Funakoshi will distribute Celox's complete line of cell biology products to biotechnology, medical and pharmaceutical companies, and for use in academic research throughout Japan.
 "Our major distribution objective is to market our products globally," said Milo R. Polovina, Celox's president and CEO. "This new partnership introduces our products to Japan, which is anxious for Celox's new and proven technology."
 Similar agreements have been recently executed, including one with TechGen International to distribute Celox's products in Europe, and Intermountain Scientific Corporation, which has commenced distribution for Celox in 14 western states.
 Polovina said that Funakoshi has 25 years experience and a demonstrated success in life science research and development. "Funakoshi is a major distributor in Japan," said Polovina. "We are delighted and fortunate to have formed this mutually beneficial relationship."
 Celox Corporation researches, develops, manufactures and markets cell biology products used in academic, pharmaceutical and commercial laboratories.
 -0- 1/12/93
 /CONTACT: Milo R. Polovina, Celox Corp. president and CEO, 612-933-2616; or Gail Shore of Shore to Shore Communications, 612-925-6102, for Celox/
 (CELX)


CO: Celox Corporation ST: Minnesota IN: MTC SU:

KH -- MN006 -- 3950 01/12/93 10:57 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 12, 1993
Words:217
Previous Article:ALAMO OFFERS FREE STARLITE CRUISE TO ALL SOUTH FLORIDA CUSTOMERS
Next Article:CRAY Y-MP C90 SYSTEM INSTALLED, ACCEPTED AT PITTSBURGH SUPERCOMPUTING CENTER
Topics:


Related Articles
CELOX ANNOUNCES PUBLIC OFFERING
CELOX CORPORATION ANNOUNCES PUBLIC OFFERING
CELOX SIGNS WESTERN STATES DISTRIBUTION PACT
CELOX DELIVERS FIRST SHIPMENT TO JAPAN
CELOX FILES WITH FDA FOR NEW REGISTRATION STATUS TO BECOME A MEDICAL DEVICE COMPANY -- WILL ALLOW COMPANY TO ENTER NEW BIOTECH MARKETS
CELOX BEGINS DISTRIBUTION AGREEMENT IN TAIWAN
CELOX ANNOUNCES ADDITION TO BOARD OF DIRECTORS
CELOX CORPORATION ANNOUNCES COLLABORATION WITH MEMORIAL BLOOD CENTERS OF MINNESOTA
CELOX CORPORATION ANNOUNCES NAME CHANGE AND ADDITIONAL ACTIVITIES AT ANNUAL MEETING
Celox Laboratories, Inc. Receives International Patents on ViaStem.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters